Exome scale map of genetic alterations promoting metastasis in colorectal cancer

Area of Science:

• Genomics and Molecular Biology
• Oncology
• Cancer Metastasis Research

Background:

• Colorectal cancer (CRC) metastasis is responsible for approximately 90% of cancer deaths.
• While over 40 genes are linked to CRC development, none have been definitively associated with metastasis.
• Understanding the molecular drivers of CRC metastasis is crucial for improving patient outcomes.

Purpose of the Study:

• To identify the molecular basis of colorectal cancer (CRC) metastasis.
• To investigate genetic alterations and their association with gene expression in metastatic CRC.
• To explore the link between genome-scale mutation distribution and gene expression patterns in CRC metastasis.

Main Methods:

• Whole-exome and genome-scale transcriptome sequencing of 7 liver metastases and matched primary tumors.
• Analysis of multiple, spatially separated fragments of primary tumors.
• Use of macrodissection and laser microdissection for precise tissue selection.

Main Results:

• High sequencing coverage enabled detection of genetic alterations in tumor cell subpopulations.
• Confirmed mutations in known CRC-associated genes (KRAS, APC, POLE, PTPRT).
• Identified novel potential associations with metastasis involving genes such as PLXND1, CELSR3, BAHD1, and PNPLA6.

Conclusions:

• Confirmed the role of inflammation in CRC progression, while questioning previously described matrix metalloproteinase activation mechanisms.
• Established a link between genome-scale mutation distribution and gene expression patterns in CRC metastasis.
• This study represents the first report of such an association in the context of CRC metastasis.